The Power of Pills: Social, Ethical & Legal Issues in Drug Development, Marketing & Pricing – Edited by Jillian C. Cohen, Patricia Illingworth & Udo Schüklenk [Book Review]

Developing World Bioethics 9 (1):43-45 (2009)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1471-8847.2007.00212.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,497

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Access to medicines and the role of corporate social responsibility: the need to craft a global pharmaceutical system with integrity.Jillian Clare Cohen-Kohler & Patricia Illingworth - 2008 - In Peter A. Singer & A. M. Viens (eds.), The Cambridge textbook of bioethics. New York: Cambridge University Press.
The dilemma of intellectual property rights for pharmaceuticals: The tension between ensuring access of the poor to medicines and committing to international agreements.Jillian Clare Cohen & Patricia Illingworth - 2003 - Developing World Bioethics 3 (1):27–48.
Ethical Issues in Drug Testing, Approval and Pricing: The Clot-Dissolving Drugs.Baruch A. Brody & Udo Schuklenk - 1998 - Bioethics 12 (1):79-81.
Pharmaceuticals.Margit Sutrop & Kadri Simm - 2011 - In Ruth F. Chadwick, H. ten Have & Eric Mark Meslin (eds.), The SAGE handbook of health care ethics: core and emerging issues. London: SAGE. pp. 427-439.
The Dilemma of Intellectual Property Rights for Pharmaceuticals: The Tension Between Ensuring Access of the Poor to Medicines and Committing to International Agreements.Patricia Illingworth Jillian Clare Cohen - 2003 - Developing World Bioethics 3 (1):27-48.
A call to restructure the drug development process: Government over-regulation and non-innovative late stage (phase III) clinical trials are major obstacles to advances in health care.Thomas C. Jones - 2005 - Science and Engineering Ethics 11 (4):575-587.
Philosophy of psychopharmacology: smart pills, happy pills, and pepp pills.Dan J. Stein - 2008 - New York: Cambridge University Press.
Vioxx and other pharmaceutical product withdrawals: ethical issues in ensuring the integrity of drug and medical device research, development and commercialization.K. L. Phua & F. I. Achike - 2007 - Clinical Ethics 2 (3):155-162.
Ethical Issues in New Drug Prescribing.Lindsay W. Cole, Jennifer C. Kesselheim & Aaron S. Kesselheim - 2012 - Journal of Bioethical Inquiry 9 (1):77-83.
What Counts as a 'Social and Ethical Issue' in Nanotechnology?Bruce V. Lewenstein - 2005 - Hyle 11 (1):5 - 18.
Marketing ethics.George G. Brenkert - 2008 - Malden, MA: Blackwell.
A Framework for International Marketing Ethics: Preliminary Considerations and Emerging Perspectives.Georges Enderle - 1998 - Journal of Human Values 4 (1):25-43.
Explicating Ethical Corporate Marketing. Insights from the BP Deepwater Horizon Catastrophe: The Ethical Brand that Exploded and then Imploded. [REVIEW]John M. T. Balmer, Shaun M. Powell & Stephen A. Greyser - 2011 - Journal of Business Ethics 102 (1):1-14.
The Ethical Implications of the Social Determinants of Health: A Global Renaissance for Bioethics.Patricia Illingworth - 2009 - Bioethics 23 (2):ii-v.
Ethical Issues in Drug Testing, Approval and Pricing: the Clot-Dissolving Drugs by Baruch A. Brody.U. Schueklenk - 1998 - Bioethics 12:79-81.

Analytics

Added to PP
2009-01-28

Downloads
44 (#364,497)

6 months
11 (#248,819)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references